Compound Overview Class of Compound: Peptide Mechanism of Action: PT-141 is an agonist of the melanocortin receptors, with high affinity for MC4R, the stimulation of which increases sexual desire and causes sexual arousal in both men and women Notable Studies: Also Known As: Bremelanotide, bremelanotide acetate, Rekynda, Vyleesi, CID9941379 Research Applications: Sexual funtion Male sexual arousal Anti-inflammatory action Risks: Injection-related side effects Temporarily increases blood pressure Not FDA approved to treat men
Consistent use leads to weight loss after 8-12 weeks
As soon as ghrelin or a peptide such as Ipamorelin binds to the receptor, its activity and GH release increases dramatically
Additionally, if you need to lose fewer than 10 pounds, semaglutide might not be the most appropriate approach, but we can discuss other effective strategies tailored to your specific needs
Many individuals require a higher dose titration than what they initially begin with, or are currently taking, to truly unlock the medication's full potential for weight loss
This analysis examines the regulatory timeline, enforcement actions, and what these changes mean for research-grade peptide quality assurance